News
By Jack Phillips Contributing Writer While activity for COVID-19 remains low in the United States, recent statistics released by the Centers for Disease Control and Prevention show that infections are ...
New research from the Children’s Hospital of Philadelphia shows the challenges of getting families to accept a promising new ...
3d
BabyCenter on MSNIs it safe to get vaccinated during pregnancy?
Find out which vaccines are recommended while you're pregnant to protect you and your baby, and which you'll need to wait on.
A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...
A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...
4d
BabyCenter on MSNWhat to know about the RSV vaccine during pregnancy
Find out whether you should get the RSV vaccine, known as Abrysvo, during pregnancy and when it's recommended.
“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...
Each year, almost 200,000 adults 65 and older are hospitalized due to RSV, and an estimated 14,000 of those cases result in ...
6d
What to Expect on MSN7 Things to Know About Infant Vaccines Before Baby Arrives
While your baby may not have made his big entrance yet, it's important to understand the recommended vaccines and schedule now. That's because your child’s immunizations will play a major role during ...
7d
Zacks Investment Research on MSNFDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger Adults
GSK plc GSK announced that the FDA has accepted its regulatory filing seeking to expand the use of its RSV vaccine, Arexvy, in adults under 50 who are at a higher risk of the disease. A final decision ...
7d
Pharmaceutical Technology on MSNGSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients
The label expansion sought by GSK is a bid to compete with Pfizer and Moderna in the younger age groups of the RSV vaccine market. Pfizer’s Abrysvo and Moderna’s mRESVIA are both approved to prevent ...
The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results